[1] |
陈志,周宗科.髋、膝关节置换术后假体周围感染的诊治进展[J].实用骨科杂志,2017,23(3):247-251.
|
[2] |
Willis-Owen CA, Konyves A, Martin DK. Factors affecting the incidence of infection in hip and knee replacement an analysis of 5277 cases[J]. J Bone Joint Surg Br, 2010, 92B(8): 1128-1133.
|
[3] |
Kapadia BH, Berg RA, Daley JA. Periprosthetic joint infection[J]. Lancet, 2016, 387(10016): 386-394.
|
[4] |
Font-Vizcarra L, Garcia S, Martinez-Pastor JC, et al. Blood culture flasks for culturing synovial fluid in prosthetic joint infections[J]. Clin Orthop Relat Res, 2010, 468(8): 2238-2243.
|
[5] |
陈志,周宗科,沈彬,等.急性、迟发性、慢性假体周围感染的诊病原学特征及疗效分析[J].实用骨科杂志,2019,25(4):313-316.
|
[6] |
Parvizi J, Zmistowski B, Berbari EF, et al. New definition for periprosthetic joint infection: from the workgroup of the musculoskeletal infection society[J]. Clin Orthop Relat Res, 2011, 469(11): 2992-2994.
|
[7] |
Parvizi J, Erkocak OF, Della Valle CJ. Culture-negative periprosthetic joint infection[J]. J Bone Joint Surg Am, 2014, 96(5): 430-436.
|
[8] |
Trampuz A, Piper KE, Jacobson MJ, et al. Sonication of removed hip and knee prostheses for diagnosis of infection[J]. N Engl J Med, 2007, 357(7): 654-663.
|
[9] |
Malhas AM, Lawton R, Reidy M, et al. Causative organisms in revision total hip & knee arthroplasty for infection: Increasing multi-antibiotic resistance in coagulase-negative staphylococcus and the implications for antibiotic prophylaxis[J]. Surgeon, 2015, 13(5): 250-255.
|
[10] |
Tsai JC, Sheng WH, Lo WY, et al. Clinical characteristics, microbiology, and outcomes of prosthetic joint infection in Taiwan[J]. J Microbiol Immunol Infect, 2015, 48(2): 198-204.
|
[11] |
Osmon DR, Berbari EF, Berendt AR, et al. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America[J]. Clin Infect Dis, 2013, 56(1): e1-e25.
|
[12] |
Anguita-Alonso P, Hanssen AD, Osmon DR, et al. High rate of aminoglycoside resistance among staphylococci causing prosthetic joint infection[J]. Clin Orthop Relat Res, 2005, 10(439): 43-47.
|
[13] |
Papadopoulos A, Ribera A, Mavrogenis AM. (MDR)and extensively drug resistant(XDR)Gram negative prosthetic joint infections(PJI): role of surgery and impact of colistin administration[J]. Int J Antimicrob Agents, 2019, 53(3): 294-301.
|
[14] |
Finley R, Glass-Kaastra SK, Hutchinson JA, et al. Declines in outpatient antimicrobial use in Canada (1995-2010)[J]. PLoS One, 2013, 8(10): e76398.
|
[15] |
Marschall J, Lane MA, Beekmann SE, et al. Current management of prosthetic joint infections in adults: results of an emerging infections network survey[J]. Int J Antimicrob Agents, 2013, 41(3): 272-277.
|
[16] |
Dubee V, Zeller V, Lhotellier L, et al. Continuous high-dose vancomycin combination therapy for methicillin-resistant staphylococcal prosthetic hip infection: a prospective cohort study[J]. Clin Microbiol Infect, 2013, 19(2): E98-E105.
|
[17] |
Tande AJ, Gomez-Urena EO, Berbari EF, et al. Management of prosthetic joint infection [J]. Infect Dis Clin North Am, 2017,31(2): 237-252.
|
[18] |
Van Erp, Heineken AC, Van Wensen RJA, et al. Optimization of the empirical antibiotic choice during the treatment of acute prosthetic joint infections: a retrospective analysis of 91 patients [J]. Acta Orthop, 2019,90(5):455-459.
|
[19] |
Ascione T, Balato G, Mariconda M, et al. Continuous antibiotic therapy can reduce recurrence of prosthetic joint infection in patients undergoing 2-stage exchange [J]. J Arthroplasty, 2019,34(4):704-709.
|
[20] |
Sousa R, Abreu MA. Treatment of prosthetic joint infection with debridement, antibiotics and irrigation with implant retention-a narrative review [J]. J Bone Jt Infect, 2018,3(3): 108-117.
|